Person Closely Associated Dealing
In brief · summary, not quotable
Person closely associated with Chief Innovation Officer exercised options and sold shares.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 30 April 2025: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that Pippa Radcliffe, a person closely associated with Dr. Kyriacos Mitrophanous, Chief Innovation Officer of the Company, exercised 1,209 options at nil exercise price and disposed 1,209 shares at £2.9785 per share on 30 April 2025.
| a) | Name | Pippa Radcliffe | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | This notification concerns Pippa Radcliffe in her capacity as a person closely associated with a person discharging managerial responsibilities. The person discharging managerial responsibilities is Dr. Kyriacos Mitrophanous, Chief Innovation Officer of the Company. The association arises by virtue of Pippa Radcliffe being the spouse of Dr. Kyriacos Mitrophanous. | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-04-30 | ||||
| b) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Exercise of Options at nil exercise price | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 1,209 £0.00 £0.00 | ||||
| a) | Name | Pippa Radcliffe | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | This notification concerns Pippa Radcliffe in her capacity as a person closely associated with a person discharging managerial responsibilities. The person discharging managerial responsibilities is Dr. Kyriacos Mitrophanous, Chief Innovation Officer of the Company. The association arises by virtue of Pippa Radcliffe being the spouse of Dr. Kyriacos Mitrophanous. | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Name | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-04-30 | ||||
| b ) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of transaction | Sale of shares | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 1,209 £2.9785 £3,601.01 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.